Bionano Genomics Inc. (BNGO)
NASDAQ · Healthcare
Bionano Genomics Inc. Net Income 2017–2025
Bionano Genomics Inc. annual/quarterly net income history and growth rate from 2017 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Bionano Genomics Inc. net income for the quarter ending March 31, 2026 was -8.3 M, a 167.67% increase year-over-year.
- Bionano Genomics Inc. net income for the twelve months ending March 31, 2026 was -26.8 M, a 86.91% decrease year-over-year.
- Bionano Genomics Inc. annual net income for 2025 was -26.4 M, a 76.44% decrease from 2024.
- Bionano Genomics Inc. annual net income for 2024 was -112.0 M, a 51.82% decrease from 2023.
- Bionano Genomics Inc. annual net income for 2023 was -232.5 M, a 75.34% increase from 2022.
- Bionano Genomics Inc. annual net income for 2022 was -132.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bionano Genomics Inc. Net Income — FAQ
Bionano Genomics Inc. (BNGO) net income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Bionano Genomics Inc.'s net income?
Bionano Genomics Inc. (BNGO) reported net income of -$26M for fiscal 2025.
Where can I see BNGO's net income history?
The chart and table above show Bionano Genomics Inc.'s net income by year and by quarter, including the growth rate.